C12N 2730/10034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2730/10034 (Use of virus or viral component as vaccine) appears on 8 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 13
- Assignees
- 11
- Inventors
- 27
- Latest grant
- 21 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 4 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 3 |
| 2023 | 2 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Arthrospira platensis oral vaccine delivery platform21 Oct 2025US 12,447,202 B2Lumen Bioscience, Inc.
- Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof24 Oct 2023US 11,793,869 B2Serum Institute of India Pvt Ltd
- Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use3 Oct 2023US 11,771,759 B2Fudan University
- Thermostable vaccines based on ether lipids and native viral envelope proteins26 May 2020US 10,660,854 B2Batavia Biosciences Inc.
- Rodent hepadnavirus cores with reduced carrier-specific antigenicity28 May 2019US 10,300,124 B2VLP Biotech, Inc.
- Hepatitis B Virus Receptor OATP and Use Thereof21 May 2026US 2026/0137774 A1Shanghai Hep Pharmaceutical Co., Ltd.
- Arthrospira platensis oral vaccine delivery platform21 Aug 2025US 2025/0262287 A1Lumen Bioscience, Inc.
- Hybrid virus-like particles and use thereof as a therapeutic hepatitis b vaccine29 Dec 2022US 2022/0411475 A1VLP Biotech, Inc.
- Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use9 Jun 2022US 2022/0175912 A1Fudan University
- Conformational epitope of hepatitis b surface antigen and antibody binding specifically thereto14 Apr 2022US 2022/0112246 A1The Green Cross Corporation
Most cited
By later US patents
- Method of making modified immunodeficiency virus particles3US 7,439,052 B2Lipid Sciences, Inc. · 2008
- Rodent hepadnavirus cores with reduced carrier-specific antigenicity1US 10,300,124 B2VLP Biotech, Inc. · 2019
- Recombinant polynucleotide and a transgenic Flammulina velutipes carrying the same1US 9,528,093 B2Mycomagic Biotechnology Co., Ltd. · 2016